logo
logo

Co Diagnostics, Inc. announced it raised $46.6 Million in an initial filing from an offering of $47.2 Million

Jan 14, 2022over 3 years ago

Amount Raised

$46.6 Million

Salt Lake CityHealth DiagnosticsManufacturingBiotechnologyHealth Care

Company Information

Company

Co-Diagnostics, Inc.

Location

2401 South Foothill Drive

Salt Lake City, Utah, United States

About

At Co-Diagnostics, we are passionate about providing the most robust and innovative molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications, especially to those regions where pricing is paramount. Our proprietary molecular diagnostics technology is paving the way for innovation in disease detection and life sciences research through our enhanced detection of genetic material. Because we own our platform, we are able to accomplish this faster and more economically, allowing for wider margins while still positioning Co-Diagnostics to be the worldwide low-cost leader of molecular diagnostics services.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People